Artigo de periodico

Systemic sclerosis and bone loss: the role of the disease and body composition (2006)

• Authors:
  • Souza, R. B. C
  • Borges, C. T. L.
  • Takayama, L
  • Aldrighi, José Mendes
  • Pereira, R. M. R.
• USP affiliated authors: ALDRIGHI, JOSE MENDES - FSP ; PEREIRA, ROSA MARIA RODRIGUES - FM
• Unidades: FSP; FM
• DOI: 10.1080/03009740600704296
• Subjects: DOENÇAS DO TECIDO CONJUNTIVO; OSSO E OSSOS; COMPOSIÇÃO CORPORAL; OSTEOPOROSE; ESTUDOS DE CASOS E CONTROLES
• Language: Inglês
• Abstract: Objectives: Studies on body composition are not available in systemic sclerosis (SSc). As this variable may play an important role in bone loss we have analysed bone mineral density (BMD) and body composition in SSc patients and healthy controls.Methods: Forty-three postmenopausal SSc patients and 47 healthy postmenopausal women were studied. Patients with intestinal malabsorption, renal failure, current or past history of smoking or using osteopenic drugs were excluded. BMD and body composition was evaluated by dual X-ray absorptiometry (DXA). Results: A higher frequency of osteoporosis in the lumbar spine (32.5 percent) and femoral neck (51.1 percent) was observed in SSc patients when compared to controls (14.8 percent vs. 19.1 percent; p<0.01). Multiple linear regression analysis revealed an association between the presence of SSc and low BMD. Body composition showed a reduced lean mass (33.15 vs. 39.99g; p<0.01) and fat mass (21.05 vs. 26.82g; p<0.01) in SSc when compared to controls. Lean mass was an important factor related to BMD in the lumbar spine and femoral neck. Conclusion: SSc may be an independent factor for low BMD. The low lean mass in these patients emphasizes the need for appropriate additional therapeutic measures to reduce bone loss in SSc patients
• Imprenta:
  • Publisher place: Stockholm
  • Date published: 2006
• Source:
  • Título: Scandinavian Journal of Rheumatology
  • ISSN: 0300-9742
  • Volume/Número/Paginação/Ano: v. 35, n. 5, p. 384-387, 2006

Informações sobre o DOI: 10.1080/03009740600704296 (Fonte: oaDOI API)
• Este periódico é de assinatura
• Este artigo NÃO é de acesso aberto
  
• Cor do Acesso Aberto: closed

---

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  SOUZA, R. B. C et al. Systemic sclerosis and bone loss: the role of the disease and body composition. Scandinavian Journal of Rheumatology, v. 35, n. 5, p. 384-387, 2006Tradução . . Disponível em: https://doi.org/10.1080/03009740600704296. Acesso em: 05 jan. 2026.

• APA

  Souza, R. B. C., Borges, C. T. L., Takayama, L., Aldrighi, J. M., & Pereira, R. M. R. (2006). Systemic sclerosis and bone loss: the role of the disease and body composition. Scandinavian Journal of Rheumatology, 35( 5), 384-387. doi:10.1080/03009740600704296

• NLM

  Souza RBC, Borges CTL, Takayama L, Aldrighi JM, Pereira RMR. Systemic sclerosis and bone loss: the role of the disease and body composition [Internet]. Scandinavian Journal of Rheumatology. 2006 ; 35( 5): 384-387.[citado 2026 jan. 05 ] Available from: https://doi.org/10.1080/03009740600704296

• Vancouver

  Souza RBC, Borges CTL, Takayama L, Aldrighi JM, Pereira RMR. Systemic sclerosis and bone loss: the role of the disease and body composition [Internet]. Scandinavian Journal of Rheumatology. 2006 ; 35( 5): 384-387.[citado 2026 jan. 05 ] Available from: https://doi.org/10.1080/03009740600704296

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• High frequency of osteoporosis and fractures in women with dermatomyositis/polymyositis
• Baixa massa magra Esta Associada a Osteoporose na Esclerose Sistemica (ES)
• Esclerose sistêmica e ostoporose, o papel da doença, composição corporal e tempo de menopausa
• Low lean body mass is associated with osteoporosis in systemic sclerosis (SSc)
• Comparison between raloxifene and hormone replacement therapy on ambulatory blood pressure and arterial stiffness
• Efeitos da terapêutica de reposição hormonal transdérmica combinada e do raloxifeno sobre a proteína C reativa e anticorpos anti-LDL oxidada
• Efeito da terapia de reposição hormonal na complacência vascular em mulheres na pós-menopausa
• Papel da terapia da reposição hormonal I: lípide, glicose, distribuição da gordura corpórea e endotélio
• Effects of hormone replacement therapy or raloxifene on ambulatory blood pressures and arterial stoffness in treated hypertensive postmenopausal women
• Estado atual da terapêutica hormonal na peri e na pós-menopausa